ICU Mortality Prediction Using XGBoost-based Scoring Systems: A Study from a Developing Country.

IF 1 Q4 PHARMACOLOGY & PHARMACY
Reema Karasneh, Sayer Al-Azzam, Karem H Alzoubi, Mohammad Araydah, Dania Rahhal, Yamin Al-Azzam, Zelal Kharaba, Suad Kabbaha, Mamoon A Aldeyab
{"title":"ICU Mortality Prediction Using XGBoost-based Scoring Systems: A Study from a Developing Country.","authors":"Reema Karasneh, Sayer Al-Azzam, Karem H Alzoubi, Mohammad Araydah, Dania Rahhal, Yamin Al-Azzam, Zelal Kharaba, Suad Kabbaha, Mamoon A Aldeyab","doi":"10.2174/0115748871348585250604065542","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Accurate mortality prediction in intensive care units (ICUs) is essential for enhancing patient outcomes and optimizing healthcare resource allocation. Traditional scoring systems, such as APACHE, APACHE II, and SAPS, have limitations in handling complex, high- -dimensional ICU data. In this study, multiple machine learning models were compared to establish an efficacious predictive model for mortality tailored explicitly to the Jordanian population and to explicate factors strongly associated with mortality.</p><p><strong>Methods: </strong>This study was conducted as a single-center, retrospective cohort investigation, and the XGBoost machine learning algorithm was used to develop a novel ICU mortality prediction model. The model aimed to achieve superior prediction accuracy using a diverse set of readily available clinical data, including demographics, comorbidities, laboratory results, and medication groups. Model performance was evaluated against alternative machine learning algorithms, including logistic regression, conventionally employed in traditional scoring systems.</p><p><strong>Results: </strong>Comparative analysis revealed that the XGBoost model performed better than other scoring systems, manifesting heightened accuracy (87.91%), sensitivity (92.88%), and Area Under the Receiver-Operating Characteristic Curve (AUC-ROC) Score/Curve (94.29%). Notably, the patient's length of hospital stays, albumin levels, and urea levels emerged as the most substantial predictors for ICU mortality, each exhibiting respective SHAP values of 0.5, 0.41, and 0.37.</p><p><strong>Conclusion: </strong>A locally adapted ICU mortality prediction model was developed, underscoring the pivotal role of predictors such as hospital stay duration, albumin, and urea levels in predicting patient outcomes. The heightened accuracy and sensitivity of the XGBoost model signify its potential as an invaluable tool in the critical task of mortality prediction within the Jordanian ICU context.</p>","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748871348585250604065542","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Accurate mortality prediction in intensive care units (ICUs) is essential for enhancing patient outcomes and optimizing healthcare resource allocation. Traditional scoring systems, such as APACHE, APACHE II, and SAPS, have limitations in handling complex, high- -dimensional ICU data. In this study, multiple machine learning models were compared to establish an efficacious predictive model for mortality tailored explicitly to the Jordanian population and to explicate factors strongly associated with mortality.

Methods: This study was conducted as a single-center, retrospective cohort investigation, and the XGBoost machine learning algorithm was used to develop a novel ICU mortality prediction model. The model aimed to achieve superior prediction accuracy using a diverse set of readily available clinical data, including demographics, comorbidities, laboratory results, and medication groups. Model performance was evaluated against alternative machine learning algorithms, including logistic regression, conventionally employed in traditional scoring systems.

Results: Comparative analysis revealed that the XGBoost model performed better than other scoring systems, manifesting heightened accuracy (87.91%), sensitivity (92.88%), and Area Under the Receiver-Operating Characteristic Curve (AUC-ROC) Score/Curve (94.29%). Notably, the patient's length of hospital stays, albumin levels, and urea levels emerged as the most substantial predictors for ICU mortality, each exhibiting respective SHAP values of 0.5, 0.41, and 0.37.

Conclusion: A locally adapted ICU mortality prediction model was developed, underscoring the pivotal role of predictors such as hospital stay duration, albumin, and urea levels in predicting patient outcomes. The heightened accuracy and sensitivity of the XGBoost model signify its potential as an invaluable tool in the critical task of mortality prediction within the Jordanian ICU context.

基于xgboost评分系统的ICU死亡率预测:一项来自发展中国家的研究
背景:重症监护病房(icu)准确的死亡率预测对于提高患者预后和优化医疗资源分配至关重要。传统的评分系统,如APACHE、APACHE II和SAPS,在处理复杂的高维ICU数据方面存在局限性。在这项研究中,对多个机器学习模型进行了比较,以建立一个明确针对约旦人口的有效的死亡率预测模型,并解释与死亡率密切相关的因素。方法:本研究采用单中心、回顾性队列研究,采用XGBoost机器学习算法建立新型ICU死亡率预测模型。该模型旨在利用各种现成的临床数据,包括人口统计学、合并症、实验室结果和药物组,实现卓越的预测准确性。模型的性能是根据其他机器学习算法进行评估的,包括传统评分系统中通常使用的逻辑回归。结果:对比分析显示,XGBoost模型的准确率(87.91%)、灵敏度(92.88%)和受试者-工作特征曲线(AUC-ROC)评分/曲线下面积(94.29%)均优于其他评分系统。值得注意的是,患者的住院时间、白蛋白水平和尿素水平成为ICU死亡率最重要的预测因素,其各自的SHAP值分别为0.5、0.41和0.37。结论:建立了适合当地的ICU死亡率预测模型,强调了住院时间、白蛋白和尿素水平等预测因素在预测患者预后方面的关键作用。XGBoost模型的高度准确性和敏感性表明,它有潜力成为约旦ICU死亡率预测关键任务中的宝贵工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews on recent clinical trials
Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-
CiteScore
3.10
自引率
5.30%
发文量
44
期刊介绍: Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信